{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:54:51Z","timestamp":1785887691830,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3500104"],"award-info":[{"award-number":["2022YFC3500104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phymed.2026.158403","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:32:17Z","timestamp":1781022737000},"page":"158403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sweroside attenuates heart failure with preserved ejection fraction via targeting PCSK9-CD36 interaction to reduce cardiac-hepatic lipotoxicity"],"prefix":"10.1016","volume":"158","author":[{"given":"Dong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aolong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-4456","authenticated-orcid":false,"given":"Shuzhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.phymed.2026.158403_bib0001","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phymed.2026.158403_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154707","article-title":"Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in golden Syrian hamsters","volume":"117","author":"Briand","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.phymed.2026.158403_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) inflammasome activation in heart failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ. Heart. Fail."},{"issue":"3","key":"10.1016\/j.phymed.2026.158403_bib0004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.3567","article-title":"Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure","volume":"27","author":"Chang","year":"2025","journal-title":"Eur. J. Heart. Fail."},{"key":"10.1016\/j.phymed.2026.158403_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113833","article-title":"Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy","volume":"271","author":"Chen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158403_bib0006","doi-asserted-by":"crossref","first-page":"10645","DOI":"10.2147\/DDDT.S522381","article-title":"Exploratory study on the role of emodin in alleviating MPTP-induced neurotoxicity: a focus on p53-ferroptosis signaling","volume":"19","author":"Chen","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"issue":"10","key":"10.1016\/j.phymed.2026.158403_bib0007","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Da Dalt","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"32","key":"10.1016\/j.phymed.2026.158403_bib0008","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/eurheartj\/ehab431","article-title":"PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction","volume":"42","author":"Da Dalt","year":"2021","journal-title":"Eur. Heart. J."},{"issue":"12","key":"10.1016\/j.phymed.2026.158403_bib0009","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 Induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158403_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria-inflammation circuit by beta-hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.phymed.2026.158403_bib0011","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jcb.30428","article-title":"Sweroside alleviates hepatic steatosis in part by activating AMPK\/mTOR-mediated autophagy in mice","volume":"124","author":"Ding","year":"2023","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.phymed.2026.158403_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155912","article-title":"Deciphering the molecular pathways of saroglitazar: a dual PPAR alpha\/gamma agonist for managing metabolic NAFLD","volume":"155","author":"Ezhilarasan","year":"2024","journal-title":"Metabolism"},{"issue":"22","key":"10.1016\/j.phymed.2026.158403_bib0013","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/CIRCULATIONAHA.124.072194","article-title":"XBP1s-EDEM2 Prevents the onset and development of HFpEF by ameliorating cardiac lipotoxicity","volume":"151","author":"Fonseka","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2026.158403_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108011","article-title":"Sweroside: a comprehensive review of its biosynthesis, pharmacokinetics, pharmacology, and safety","volume":"222","author":"Gan","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2026.158403_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106851","article-title":"A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation","volume":"194","author":"Gao","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158403_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010284","article-title":"Pathophysiology of HFpEF: insights from a metabolic-mitochondrial perspective","volume":"27","author":"Gatto","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158403_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbalip.2016.06.023","article-title":"Mitochondrial acyltransferases and glycerophospholipid metabolism","volume":"1862","author":"Gonzalez-Baro","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"18","key":"10.1016\/j.phymed.2026.158403_bib0018","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.phymed.2026.158403_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70837","article-title":"Sweroside inhibits inflammation and alleviates endothelial injury and atherosclerosis in mice","volume":"29","author":"Huang","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2026.158403_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153633","article-title":"An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG pathway","volume":"91","author":"Huang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158403_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108480","article-title":"Targeting PCSK9 to tackle cardiovascular disease","volume":"249","author":"Hummelgaard","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.phymed.2026.158403_bib0022","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2026.158403_bib0023","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","article-title":"Loss of metabolic flexibility in the failing heart","volume":"5","author":"Karwi","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"issue":"19","key":"10.1016\/j.phymed.2026.158403_bib0024","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1042\/CS20210127","article-title":"Lipotoxicity: a driver of heart failure with preserved ejection fraction?","volume":"135","author":"Leggat","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"12","key":"10.1016\/j.phymed.2026.158403_bib0025","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/s41401-024-01389-3","article-title":"SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization","volume":"45","author":"Lin","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2026.158403_bib0026","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jare.2024.12.047","article-title":"Dimeric guaianolide sesquiterpenoids from the flowers of Chrysanthemum indicum ameliorate hepatic steatosis through mitigating SIRT1-mediated lipid accumulation and ferroptosis","volume":"76","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"issue":"5","key":"10.1016\/j.phymed.2026.158403_bib0027","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3390\/ijms19051529","article-title":"The CD36-PPARgamma pathway in metabolic disorders","volume":"19","author":"Marechal","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158403_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106035","article-title":"Current and future therapeutic perspective in chronic heart failure","volume":"175","author":"Mascolo","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.phymed.2026.158403_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073668","article-title":"SGLT2 Inhibitors as the most promising influencers on the outcome of non-alcoholic fatty liver disease","volume":"23","author":"Mirarchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158403_bib0030","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41467-022-28889-2","article-title":"Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control","volume":"13","author":"Montgomery","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phymed.2026.158403_bib0031","first-page":"134","article-title":"Impact of lipotoxicity on tissue \"cross talk\" and metabolic regulation","volume":"34","author":"Montgomery","year":"2019","journal-title":"Physiology. (Bethesda)"},{"key":"10.1016\/j.phymed.2026.158403_bib0032","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.prostaglandins.2016.06.003","article-title":"Linoleic acid and the pathogenesis of obesity","volume":"125","author":"Naughton","year":"2016","journal-title":"Prostaglandins. Other Lipid Mediat."},{"issue":"8","key":"10.1016\/j.phymed.2026.158403_bib0033","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41401-024-01265-0","article-title":"Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway","volume":"45","author":"Ni","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.phymed.2026.158403_bib0034","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jchf.2024.07.006","article-title":"GLP-1 receptor agonists among patients with overweight or obesity, diabetes, and HFpEF on SGLT2 inhibitors","volume":"12","author":"Patel","year":"2024","journal-title":"JACC. Heart. Fail."},{"key":"10.1016\/j.phymed.2026.158403_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1594278","article-title":"Sweroside: unveiling broad therapeutic potential-from mechanistic insights to clinical potential","volume":"16","author":"Peng","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158403_bib0036","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMa"},{"issue":"11","key":"10.1016\/j.phymed.2026.158403_bib0037","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacbts.2021.07.010","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction","volume":"6","author":"Salah","year":"2021","journal-title":"JACC. Basic Transl. Sci."},{"issue":"7752","key":"10.1016\/j.phymed.2026.158403_bib0038","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"NatureNature"},{"issue":"2","key":"10.1016\/j.phymed.2026.158403_bib0039","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.158403_bib0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endrev\/bnab035","article-title":"The multifaceted biology of PCSK9","volume":"43","author":"Seidah","year":"2022","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.phymed.2026.158403_bib0041","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s11886-023-01918-2","article-title":"Pleiotropy of PCSK9: functions in extrahepatic tissues","volume":"25","author":"Sener","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.phymed.2026.158403_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155657","article-title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis","volume":"146","author":"Shen","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.phymed.2026.158403_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2014.07.042","article-title":"Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of sweroside in rats","volume":"969","author":"Sheng","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.phymed.2026.158403_bib0044","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158403_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103223","article-title":"Sweroside alleviates pressure overload-induced heart failure through targeting CaMK\u2161delta to inhibit ROS-mediated NF-kappaB\/NLRP3 in cardiomyocytes","volume":"74","author":"Wang","year":"2024","journal-title":"Redox. Biol."},{"issue":"14","key":"10.1016\/j.phymed.2026.158403_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029873","article-title":"Serum metabolites are associated with HFpEF in biopsy-proven nonalcoholic fatty liver disease","volume":"12","author":"Wegermann","year":"2023","journal-title":"J. Am. Heart. Assoc."},{"issue":"6","key":"10.1016\/j.phymed.2026.158403_bib0047","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.7150\/ijbs.92337","article-title":"NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease","volume":"20","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158403_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112556","article-title":"Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response","volume":"255","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158403_bib0049","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201665","article-title":"Hepatic DKK1-driven steatosis is CD36 dependent","volume":"6","author":"Yang","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.phymed.2026.158403_bib0050","article-title":"Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.phymed.2026.158403_bib0051","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart. Fail."},{"key":"10.1016\/j.phymed.2026.158403_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157694","article-title":"Ginsenoside Rd promotes cardiac regeneration through PPARG\/HMGCS2-driven ketone body metabolic reprogramming in myocardial ischemia-reperfusion injury","volume":"150","author":"Zhang","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158403_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.748173","article-title":"Correlation between liver stiffness and diastolic function, left ventricular hypertrophy, and right cardiac function in patients with ejection fraction preserved heart failure","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158403_bib0054","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41467-025-56885-9","article-title":"FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phymed.2026.158403_bib0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCULATIONAHA.123.062788","article-title":"Immune regulation of the liver through the PCSK9\/CD36 pathway during heart transplant rejection","volume":"148","author":"Zhang","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phymed.2026.158403_bib0056","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J. Hepatol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326006343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326006343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:35:45Z","timestamp":1785886545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326006343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"alternative-id":["S0944711326006343"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158403","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sweroside attenuates heart failure with preserved ejection fraction via targeting PCSK9-CD36 interaction to reduce cardiac-hepatic lipotoxicity","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158403"}}